Open AccessAD treatment during the pandemic: dupilumab does not raise COVID-19 infection risk
Author(s) -
Brian D. Rankin,
Susanne Kammerer
Publication year - 2022
Language(s) - English
Resource type - Conference proceedings
DOI - 10.55788/b8270abd
Subject(s) - dupilumab , covid-19 , pandemic , medicine , virology , immunology , disease , asthma , infectious disease (medical specialty) , outbreak